Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Susan C. Weil, M.D.
Morphotek
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Krankenhaus Nordwest
Frankfurt, Germany
- Nationales Centrum Fur Tumorerkrankungen
Heidelberg, Germany
- Sharp Healthcare
San Diego, California, United States
- St. Vincent Gynecologic Oncology
Indianapolis, Indiana, United States
- Hematology and Oncology Specialists, Llc
Covington, Louisiana, United States
- Jayne Gurtler, M.D.
Metairie, Louisiana, United States
- Hematology and Oncology Specialists, Llc
Metarie, Louisiana, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- the Center for Cancer and Hematologic Disease
Cherry Hill, New Jersey, United States
- the Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Cooper University Hospital
Voorhees Township, New Jersey, United States
- New York Oncology Hematology
Albany, New York, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Lehigh Valley Women'S Cancer Center
Allentown, Pennsylvania, United States
- Gynecology Oncology Research & Development
Greenville, South Carolina, United States
- Mary Crowley Medical Research Center
Dallas, Texas, United States
- South Texas Oncology & Hematology
San Antonio, Texas, United States
- Tyler Cancer Center
Tyler, Texas, United States
- Northern Virginia Pelvic Surgery Associates
Annandale, Virginia, United States
- Peninsula Cancer Center
Newport News, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2006
- Primary completion
- 28 Feb 2010
- Completion
- 30 Jun 2010
- Last update posted
- 9 Sept 2015
- Registered enrollment
- 58
- Registry id
- NCT00318370
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.